Quantcast
Channel: Biotechnology Forums - All Forums
Viewing all 2695 articles
Browse latest View live

Alliances in biotech-pharma - need help

$
0
0
I am a master student of Erasmus University Rotterdam, Strategic management studies. Presently, I am working on my master thesis about strategic alliances between profit-seeking organizations and non-profit-seeking organizations (i.e. government agencies, universities, research institute.), particularly in the biotech & pharmaceutical industry.

Hereby, may I ask you a favor to help me by filling in the questionnaire?

Survey Link: https://qtrial.qualtrics.com/SE/?SID=SV_85GNxMwSEobotHT
(list of questions are also listed below in Jessica's post)

It’s about how organisations collaborate with each other in terms of trusting and controlling each other. Therefore, I'm looking for alliance managers, marketing, R&D and financial controllers to participate. The questionnaire is anonymous and completing it will only take you approximately 5 minutes.

I will really appreciate your participation, which helps me to graduate my Master study. Should you request, I would send you the results of this study, which may be interesting for you as well.

Please leave a message if you're interested. The questionnaire is an online link that I can forward to you.

Thanks

Vaccines by Recombinant DNA Technology

$
0
0
A biological preparation, which evokes an immune response when administered into the body, is termed as vaccines. This usually consists of parts of pathogen in its weakened state or its products. This triggers an immune response from the body to the particular disease without actually causing the disease.

Catering to the needs of large number of diseases, numerous vaccines for a variety of diseases has been developed and still continues to do so.

Recombinant vaccines:
Biotechnology sector has also played its part in developing vaccines against certain diseases. Such vaccine which makes use of recombinant DNA technology is known as recombinant vaccines. It is also known as subunit vaccines.

Recombinant vaccines can be broadly grouped into two kinds:

(i) Recombinant protein vaccines: This is based on production of recombinant DNA which is expressed to release the specific protein used in vaccine preparation

(ii) DNA vaccines: Here the gene encoding for immunogenic protein is isolated and used to produce recombinant DNA which acts as vaccine to be injected into the individual.

Steps involved:
Production of recombinant vaccines involves the following steps:

(i) First and foremost, it is important that the protein which is crucial to the growth and development of the causative organism be identified.

(ii) The corresponding gene is then isolated applying various techniques. Further to this, an extensive study of the gene explains the gene expression pattern involved in the production of corresponding protein.

(iii) This gene is then integrated into a suitable expression vector to produce a recombinant DNA.

(iv) This rDNA is used as vaccines or is introduce into another host organism to produce immunogenic proteins which acts as vaccines.

Recombinant protein vaccines:
A pathogen upon infection produces proteins, vital for its functions, which elicit an immune response from the infected body. The gene encoding such a protein is isolated from the causative organism and used to develop a recombinant DNA. This DNA is expressed in another host organism, like genetically engineered microbes; animal cells; plant cells; insect larvae etc, resulting in the release of the appropriate proteins which are then isolated and purified. These when injected into the body, causes immunogenic response to be active against the corresponding disease providing immunity against future attack of the pathogen.
Based on the proteins involved in evoking immune response recombinant protein vaccines are of two types:

Whole protein vaccines: The whole immunogenic protein is produced in another host organism which is isolated and purified to act as vaccines.

Polypeptide vaccines: It is known that in the immunogenic protein produced, the actual immunogenic property is limited to one or two polypeptides forming the protein. The other parts of the protein may be successful in evoking an immune response but do not actually cause the disease. For eg: in the case of cholera caused by Vibrio cholerae, consists of three polypeptide chains like A1, A2, and B. The A polypeptides are toxic while B is non-toxic. Thus while producing vaccines, the polypeptide B is produced by rDNA technology and used for vaccination.

DNA vaccines:
It refers to the recombinant vaccines in which the DNA is used as a vaccine. The gene responsible for the immunogenic protein is identified, isolated and cloned with corresponding expression vector. Upon introduction into the individuals to be immunized, it produces a recombinant DNA. This DNA when expressed triggers an immune response and the person becomes successfully vaccinated. The mode of delivery of DNA vaccines include: direct injection into muscle; use of vectors like adenovirus, retrovirus etc; invitro transfer of the gene into autologous cells and reimplantation of the same and particle gun delivery of the DNA.
In certain cases, the responsible gene is integrated into live vectors which are introduced into individuals as vaccines. This is known as live recombinant vaccines. Eg: vaccinia virus. Live vaccinia virus vaccine (VV vaccine) with genes corresponding to several diseases, when introduced into the body elicit an immune response but does not actually cause the diseases.

Advantages:

(i) Since it does not involve actual pathogen, recombinant vaccines is considered to be safe than the conventional vaccines.
(ii) It induces both humoral and cellular immune response resulting in effective vaccination.

Risks involved:
(i) High cost of production.
(ii) Have to be stored at low temperature since heat destabilizes protein. Hence storage and transportation is tedious.
(iii) Individuals with immunodeficiency may elicit poor immune response.

Oral vaccines: a novel approach
The latest hot spot in the field of vaccine research is the development of vaccine which can be taken orally. Immunogenic protein of certain pathogens is found to be active when administered orally. The gene corresponding to such proteins is isolated and a gene construct is produced. This is introduced and expressed in a plant genome which results in production of such immunogenic proteins in the parts of the plant where it is expressed. These when fed into animals or mainly humans, the person becomes vaccinated against certain pathogen. Such vaccines are also known as edible vaccines. An exciting invention is production of ‘melt in the mouth’ vaccines that can be administered by placing them under your tongue which delivers it into the blood stream. The most important example is the production of flu vaccine by Bacillus which melts in the mouth. The tremendous benefit of such vaccines is the comfort of administration, low cost and ease of storage.

Artificial Haemoglobin - Blood Substitute for Substituting Blood

$
0
0
Human haemoglobin is available in abundance. It is also one of the most sought after protein available. Haemoglobin has been studied so extensively that all the properties and expression mechanisms is well known. This makes it easier to develop haemoglobin artificially (blood substitute) to fulfil the rising demand of haemoglobin.

Mechanism involved:
Human haemoglobin basically consist of two parts mainly heme and globin. The heme portion of the protein is common among many organisms. This property can be exploited to produce haemoglobin artificially by using recombinant DNA technology. In the production of recombinant haemoglobin, only the globin part needs to be integrated and expressed. Since it naturally produces the heme part, this proves to be an easy method to produce active haemoglobins. As in such host animals the native haemoglobin serves the similar function, recombinant protein is successfully expressed.

Different organisms serve as hosts to haemoglobin production. This include

Microbial host: In microbes, the gene encoding the heme part, which produces heme identical to human haemoglobin, is first isolated and purified and then combined with globin structure isolated from human blood. Thus a proper functional haemoglobin gene is inserted in vitro into a microbial cell and the expression of the same releases haemoglobin into the cell. This haemoglobin, produced inside a microbial system, can be easily isolated and purified. The major disadvantages involved are the high cost of production involved in this technique.

Mammalian host:
The haemoglobin production in mammals involves production of transgenic animals. The genome of such animals is integrated with genes responsible for production of haemoglobin. In this technique, it is possible to determine the amount of haemoglobin genes to be expressed by controlling the genome of transgenic animals. Thus the expression levels can also be easily regulated to increase or decrease production. The main disadvantage of the process is time required to produce actual results.

Functions
The main function of blood with respect to natural haemoglobin is to act as a carrier for oxygen. Apart from this, blood also exhibits several other functions like immunity by white blood cells, blood clotting by platelets, electrolyte balance, and several other functions by blood proteins. The blood substitute is expected to fulfil some properties of blood if not all. Research corresponding to production of actual blood compiling various functions of blood is also initiated.

Advantages of blood substitute
(i) High production rate:
By producing blood substitutes, it is possible to supply blood as the demand arises.
(ii) Production of haemoglobin exhibiting specific characteristics:
As a result of rDNA technology, the recombinant haemoglobin produced exhibit several desired properties.
(iii) In depth analysis of blood related disease: since the blood substitute resembles haemoglobin closely, the study of mutations or disease affecting haemoglobin can be studied buy inducing such defects in the blood substitute.
(iv) Gene therapy:
The defective gene responsible for certain diseases like anaemia and thalassemia can be treated by gene therapy. It is also a proposed cure for inherited hemoglobinopathy
(v) Protein delivery: It can also acts as a carrier for certain biomolecules like proteins.
(vi) Safe blood transfusion: Blood substitute can be used in the place of blood for transfusion. Since it is produced artificially under sterile conditions, safe and infectious free blood can be transfused to affected people.

Disadvantages:
(i) Renal toxicity: Filtration of blood with blood substitute particles has found to affect kidneys adversely. As a result, cases which indicate renal toxicity in persons with blood substitutes is reported.
(ii) Other side affects like hypertension, fatigue is also known
(iii) This is also known to induce heart attacks.
(iv) Since animal and human haemoglobin share many properties, the separation of recombinant protein from animal ones after production proves to be difficult.
(v) It is not economical to produce on larger scale.
(vi) It is less stable and has to be transfused immediately rather than normal blood which has extended shelf life, comparatively.

Future prospects:
The stem cell research has been suggested as a very prospective area wherein the human haemoglobin can be isolated in its natural form and developed on larger scale. The haemoglobin protein can be isolated from stem cells collected and cultured to produce the same under invitro conditions. Since in this technology, the human haemoglobin is isolated in its original form, complexities due to a foreign substance in the body does not arise. All the vital functions of blood will be fulfilled by blood produced by stem cell technology.

The Jumping Genes and their Applications

$
0
0
Every single gene possess a distinct and definite location in a particular chromosome. This is well established by the ability to reconstruct gene maps using various physical methods and gene techniques. Besides this, the suspicion on gene relocation triggered researches to find out that some of the genes can actually relocate (change its position) in a chromosome. The relocation of the genes were identified to be the occurrence of two phenomenon like mispairing or unequal recombination and the presence of commuting elements called as Transposons. Transposons are one among the other two mobile genetic elements like episomes and cassettes.

Transposons are the genes present as the segments of DNA, able to commute independently from one site to the other on a chromosome. The DNA with transposon genes are also called as the selfish DNA or mobilized DNA. Transposons are also classified as mutagens. They are called by different names like mobile genes, jumping genes, roving genes etc. The scientist Barbara Mc Clintock is the founder of Transposon, as she was the first person to discover the presence of such mobilizing elements in maize crop.

The Different Transposons: Transposons were classified into prokaryotic transposons and Eukaryote transposons based on their existence in the type of cell. Prokaryote transposons have sub classes like insertion transposon first identified in E. coli and Transposons. The latter possess the genes that not only encode for the enzyme transposase but also encode genes for antibiotic resistance and heavy metal resistance. The process of transposition was found to be not frequent. Also the insertion type of translocation occurring in bacteria can be transferred either vertically to bacteria of the same species or horizontally to the bacteria of the different species.

The Eukryotic transposons are divided into two major groups called as class I transposon and class II transposon. The class I transposons are retrotranposons which undergoes two phases before fixing themselves into a new location. Retrotranposon commutes to the new location on a chromosome by first transcribing into RNA and then reverse transcribing into DNA. The former step is induced by the action of the enzyme RNA polymerase II or RNA polymerase III and the reverse transcription is due to the action of the reverse transcriptase enzyme. The long terminal repeats (LTR), long interspersed elements (LINEs) and short interspersed elements (SINEs) forms the class I transposons.

The class II transposons are those elements which relocate as DNA itself from the origin site to the target site (not RNA mediated). Transposase is the enzyme involved in this activity which snaps the new location, creating glue ends enabling the cut DNA to paste into the new site. The family of transposon elements is composed of autonomous members and non autonomous members. The autonomous members are like earning members in a family who code for their own transposition and non autonomous members are like non earning members in a family who always depend on the autonomous member for their movement into new location. Few examples of the identified class II transposable elements are Ac – Ds element in maize, Tam element in Antirrhinum, p element in Drosophila, Ty element in yeast, Tc1 element in the worm species Caenhorabditis elegans and Alu in humans.

Transposable elements are known mutagens and considered as rich source of mutation. The type of mutation caused by the transposable elements is the insertion mutation. Some of the diseases associated with the mutagenic property of transposons are cancer, muscular dystrophy, hemophilia A & B, porphyria and immunodeficiency.

The definite frequency at which the transposons relocate to a new site is considered as the unique property of transposons. The mutation causing property of transposons has derived ways for multiple applications in the field of medicine, genetics, gene therapy and biotechnology. Characterization of various strains of the species Plasmodium falciparum, the major source responsible for malaria in humans is made possible by the use of transposons as markers in clinical studies. Identification of carriers of genes responsible for diseases like sickle cell trait and Down’s syndrome is made possible by using transposon as a genetic tool. Also transposons are identified as suitable vectors in Transformation mode of gene transfer. Transposons are applied in molecular genetics which involves gene isolation and they are also used to construct gene maps. The research on transposons as tools for genetics and gene therapy are underway in the labs of Zsuzsanna Izsvak and Zoltan Ivics at Max Delbruck center for molecular medicine.

Gene Knockout and Knockout Mouse

$
0
0
Gene knockout is a genetic process by which an existing gene function can be blocked by destroying a specific gene and such organisms are called "Knockouts". There is a loss of function in transgenic animal in the gene knockout which is in contrast to gaining function in introducing a foreign gene. The knockout technique is carried out by incorporating a DNA sequence (usually a selectable marker) into coding region. The chromosome carrying the target gene (with four exons) with flanking sequences is subjected to homologous recombination with a vector carrying a selectable marker gene. This homologous recombination results in Gene Knockout.

Gene knockout has many applications, especially done for research purpose; it also provides information about what that gene normally does. It is also an efficient method to study about the gene that has been sequenced but hardly known for its function. The biochemical and pathological basis of human diseases can be understood by inactivating specific genes. For these purposes the researchers produced a knockout mouse which lack genes for a single organ or an organ system.

As humans share many genes with mice and mice being animal closely related to humans knockout experiments are carried out on mice. Knockout mice also offer great opportunity in development and testing of drugs and therapies. There are many examples in which knockout mice had been useful for studying different kinds of diseases like- arthritis, anxiety, cancer, diabetes, heart diseases, obesity and Parkinson disease. Knockout mouse is a genetically engineered altered mouse lacking the genes or inactivated gene for an entire organ or organ system. These mice exhibits changes in phenotypic characters as well as behavioral and biochemical characteristics. As an example of knockout mice is p53 knockout mouse, named after gene p53 coding for a protein that suppresses growth of tumors by arresting cell. The knockout mouse is usually named after the gene that has been inactivated.

The typical procedure of producing knockout mice involves several steps. First the gene intended to be knocked out is isolated from mouse gene library, followed by engineering a new DNA sequence resembling the original gene. DNA sequence should carry a marker gene which is usually not present in the normal mice’s gene. This marker gene helps in observing the changes. Simultaneously, stem cells are isolated from mouse blastocyst and grown invitro. Then by incorporation technique the DNA sequence is incorporated into the grown stem cells. By the process of homologous recombination takes place, where in altered cells will have new sequence. Now the stem cells from the unaltered cells are isolated using marker gene and incorporated into mouse blastocyst. This blastocyst now carries both original and knockout cell, and implanted into female mice uterus for development. The newborn mice is the recombinant mice exhibiting characters of both stem cells (original and knocked out stem cells) differently in various parts of body, i.e. a chimeric mouse showing patches of grey and white. When such mice is crossbred with the wild type some of the offspring would carry copy of knockout gene in all their cells, but these mice would be white in color even after being heterozygous. Further if these heterozygous offspring are interbred, the progeny would contain few offspring inheriting knockout genes from both parents carrying no functional copy of the original gene.

Limitations with knockout mice have been discussed by National Institutes of Health, which mentions that about 15% of knockout mice are developmentally lethal i.e. they do not grow to adulthood which hinders the study of genes’ function in the embryonic and adult stage. Then other limitation is that some genes are really difficult to knockout. Sometimes knocking out fails to produce an observable change in the mice or may exhibit drastically different characteristics from those observed in human despite of same gene’s inactivation. Also sometimes there are certain developmental defects and die whilst as embryos.

There are few knockout mice that have been useful in studying human health. Knockout mouse for transplantation in which liver cells are destroyed, using suicide gene, that lacks immune system. In this mouse sample human liver cells were transplanted which could develop because of lack of immune system. This way organ transplantation is made possible in animals. SCID mice were developed by eliminating a single gene and the resultant mice lost ability of producing B-lymphocytes and T-lymphocytes, from which human mouse was developed. Knockout mice with memory loss were developed by gene knockout technique, where the mice lack hippocampus – specialized area believed to memory processor in brain. Research on knockout mice for allergy is undergoing and it is expected in near future to benefit millions of sufferers of allergic reactions.

Drug Designing to Produce Designer Drugs

$
0
0
Drug designing is a process of constructing ailments specific drugs adopting the known properties of diseases applying different technologies.

Small organic molecules which bind and modulate the properties of specific biological receptors or targets is known as drugs. These receptors are mostly protein molecules which perform several important functions and are vital for the proper functioning of the cell. In case of abnormalities, these receptors get affected and are reflected as minor or major physical symptoms. Drugs acts to alter the defective receptors to restore its actual functions helping in treating the symptoms.

Drug Designing :
The process of constructing ailments specific drugs adopting the known properties of diseases applying different technologies is known as drug designing. This aims at designing drugs which can specifically and selectively bind to the target sites thereby modifying the same. Drug designing techniques employing computer based techniques is known as computer-aided drug design and those based on the information on the three dimensional structure of targets is known as structure– based design.

Tasks involved in drug designing:
(i) Analyse medical condition to determine the target site.
(ii) In-depth knowledge of the critical sites of target molecules.
(iii) Designing of drugs which specifically target the receptor molecules.
(iv) Synthesis and administration of drugs.
(v) Assessment of the drug-target interaction and record of the same.
(vi) Execute any necessary modification required.

Successful examples of drug designing:
Propanolol: It is one of the successful examples in drug designing.This drug is used as a treatment against heart attacks and hypertension. The heart ailments are mostly caused by excess amount of epinephrine and norepinephrine hormones. Both these hormones consist of alpha and beta receptors. The propanolol is so designed so that it binds with the beta receptors inactivating the hormones.

Cimetidine: This drug is useful in the treatment of stomach ulcers. In stomach ulcers, there is excess release of Hcl into the stomach induced by the histamine. Cimetidine blocks the binding of histamine to its H2 receptor present in the stomach lining blocking the Hcl release and thus cures the ulcer.

Drug delivery:
After a drug has been designed the next major step involved is the delivery of the drugs into the system. The normal routes of drug delivery are oral or parenteral. While following these common methods, drug delivery is not specific as it is distributed over the whole body. This demand administration of higher doses and may not always evoke a positive response. Other complications are proteolytic degradation of orally administered protein drugs, less permeability of such drugs owing its larger structure. As a result various other mechanisms have been developed for more efficient delivery of drugs:

(i) Delivery by alternative routes- other routes such as nasal, vaginal, anal, ocular, etc can be used while using protein based drugs. In order to improve the efficiency of such delivery, permeability enhancers to improve the permeability of drugs can be used. Commonly used enhancers are sodium deoxycholate, sodium glycocholate etc

(ii) Liposomes- these are artificially composed lipid vesicles. Drugs can be encapsulated in liposome and administered. Tissue specificity of liposome can be accentuated by use of specific surface ligands.

(iii) Polymers: Polymers, which are biodegradable, have been used extensively for successful delivery of drug; the drug is released by cleavage of drug fro polymer. This procedure is used for slow release of drugs of larger size.

(iv) Drug targeting: the procedure involving site directed delivery of drugs is known as drug targeting

Drug targeting
It is one of the most effective mechanisms involved in delivery of drugs to specific location or specific targets. The principle of such a mechanism is based on monoclonal antibodies.

In monoclonal antibodies, all the antibodies present in one single preparation reacts specifically with only one target. This property aids in drug targeting. The most widespread application in the use of monoclonal antibodies in this context is as immunotoxins. Monoclonal antibodies are linked with a toxin polypeptide to form immunotoxins. The target specific antibodies ensure selective and specific binding and the toxin in the immunotoxins inactivates or kills the targets.

Ricin: an example of immunotoxins and drug targeting tumour cells
The natural toxin ricin is isolated from endosperm of castor. It consists of two polypeptide chains called as A and B where the polypeptide A accounts for its toxicity. The immunotoxin formed as a conjugate between an antibody and ricin A chain results in specific binding to tumour cells and irreversible enzymatic modification of ribosomes preventing protein synthesis is such cells.

How to grow cancer cells on agar/ soft agar

$
0
0
I am a biotech postgraduate working in a microbiology lab.I have tried a lot of techniques to grow the cancer cells.but was not sucessful.i have read many articles relating to this from my searches in google.
My query is that can i grow cancer cells on soft agar from the blood or wat other medium should i use to let them grow.
secondly wat conditions should i maintain for them to grow like temperature,etc.
lastly what is the incubation time.

Plastic From Nature-Bioplastic

$
0
0
Bioplastics are a kind of plastic, produced from natural compounds, and can be degraded into their base compounds. It is also known as Biodegradable plastics.

Genetic variations in plants have been made possible through many conventional methods since many years. The biotechnological approach for the desired plant was achieved by genetic engineering. Transgenes refers to gene or genes which are not native of an organism and are introduced by many methods. Transgenic plants refer to plants having one or more transgenes. This technique of involving plants to produce various chemical commodities and pharmaceuticals is known as phytofermentation.

A variety of biochemicals such as proteins, lipids and carbohydrates are obtained from plants. Production of transgenic plants has resulted in generating modified biochemical production in plants.

Bioplastic
A reasonable amount of interest has been developed in the field of bioplastic as a result of increased concern about non degradability of plastics and environmental hazards. Bioplastic have been known to be produced by various means including vegetable fats, cornstarch etc

Biotechnological role:
The role of biotechnology in the field of bioplastic has been accounted mainly to the presence of the property of biodegradation by naturally occurring polyhydroxy- alkanoates(PHAs). These are naturally occurring polyesters produced by bacterial fermentation. Polyhydroxybutyrate(PHB) is a form of PHA. It is produced in the bacterial cell as a result of physiological stress in the form of energy storing molecules. These PHAs are metabolized and used up by such bacteria when none of the other forms of energy source is available under conditions of stress. The properties of PHB include non toxic, water insoluble, high oxygen permeability and ultra violet resistance, thermostable and biocompatible.

Bacterial fermentation of Alcaligenes eutrophus produces polyhydroxy alkanoates.

The organism is cultured under normal conditions to attain stable growth. The conditions of the medium are then altered so that the bacterium induces production of PHA. This is usually induced in deficiency conditions of macro elements, oxygen etc or due to the excess presence of carbon sources in the medium. Acetyl-coA serves as a precursor in the production of polyhydroxy alkanotaes. The microbial fermentation of Alcaligenes for the production of PHAs is not favourable as the yield is very low. The cost involved in such mechanisms is substantially higher.
Though plants do not produce PHB naturally, they can be programmed to do so. For the production of PHBs by genetic engineering, the two genes involved in the production of enzymes namely, aceto-acetyl-CoA reductase (phbB) and PHB synthase (phbC) are isolated. These two enzymes are pivotal in the PHB synthesis from its precursor. The genes responsible are transferred and expressed in Arabidopsis thaliana plant. These two genes are so targeted so that they are expressed in plastids of plant. The PHB gets accumulated in leaves and can be extracted easily.
Thus synthesis of polyhydroxyl butyrate is a classic example of application of biotechnology in the production of goods of commercial value. Transgenic trees producing phbB and phbC are also produced where the PHB are synthesised in the leaves which can be extracted. Studies shows that plant produce PHB 20 -40% of their dry mass.
This method of production involves many advantages like;
(i) Upstream production (the production of biomass from which the biochemical has to be isolated) costs are much lower than microbial fermentation.
(ii) The post translation modification system of proteins in a plant cell is as advanced as in the animal cell. As a result the PHB which is formed undergo appropriate modification so that when extracted they do not require any further modification.
(iii) The plant seeds of transgenic plants can be stored and transported easily. These seeds could be used to produce transgenic plants to synthesize bioplastic when required.
(iv) Since animal system is not used, it does not face any concerns regarding to ethical issues.

Disadvantages:
(i) The production levels do not rise to the expected levels.
(ii) The increased level of trangenes in a plant genome results in accumulation of transgenic product. This can effect the plant growth and stability.

Recent Developments:
Several studies involving production of PHB in corn, potato etc has been initiated. Transgenic tobacco plants have also been extensively studied for PHB production. It is also estimated that potatoes can be a good source of PHB production from which PHB can be easily obtained and the resulting yield is also proposed to be higher is such ‘plastic potatoes’. If successful, it will be he most cost effective method involved.

A New Kinetic Structured Model for Cell Cultivation in a Chemostat

$
0
0
We propose a new mathematical model for cell cultivation in a chemostat. Our model is based on the structuring of the biomass into two main groups: dividing and nondividing cells. The model is applicable both to existing static characteristics such as the Monod model and to the deviations from it.

We determined the range of chemostat stability at the specified flow rate D and concentration of the input limiting substrate S0. We also proposed the methods for determining parameters of the chemostat structured model.

The value of the derivative of dividing cells to nondividing cells of zero age is constant for a given flow rate. That value is no less important than the equality of specific growth rate and nutrient flow rate, which determines the equilibrium of the chemostat.

We showed that the corresponding specific rate constants of limiting substrate use by dividing and nondividing cells determine the system equilibrium. We also demonstrated that the new proposed structured model of the chemostat is more general than any other existing model. In each specific case, the model provides comparable equations to the well-known models of Monod, Pirt, Moser, Andrews and Ierusalimsky.

http://www.bioprocessintl.com/journal/20...tat-335634

Formation and Characteristics of tRNA, rRNA and mRNA

$
0
0
The Ribonucleic acid (RNA) exists as three forms in a cell. They are transfer RNA or tRNA, Ribosomal RNA or rRNA and Messenger RNA or mRNA. The messenger RNA as the name implies is carrier of information from DNA to the protein factory of the cell called as the ribosome. In ribosome, the information carried by the mRNA is read by rRNA and they participate in the conversion of the received information into proteins through a process called translation with the help of the tRNA.

Transfer RNA (tRNA): tRNAs are tiny in nature and acts as a tool in translation of mRNA into proteins by linking the base pairs of mRNA and amino acid sequence on a polypeptide. Transfer RNAs are amino acid specific and it scans and detects the parts of mRNA coding the type of aminoacid and enables the exact placement of the aminoacid in the polypeptide chain. The physique of the tRNA molecule resembles that of a clover leaf with several extended loops. They are acceptor arm, Dihydrouracil arm, anticodon arm and TⱷC arm each having a special function.

The acceptor arm as the name indicates acts as the site for aminoacid attachment and the anticodon arm detects the codons in mRNA and aids in their binding. RNA polymerase III is the active enzyme in the process of tRNA synthesis which involves transcription of genes corresponding to tRNA. The sequential array of the nucleotides in tRNA is susceptible to modification by chemical groups which contribute to methylation, saturation of double bond, deletion of amino group, replacement by sulfur group and so on.

Ribosomal RNA (rRNA): rRNAs are the native RNAs of the cell organelle Ribosome (protein factory) and hence the name Ribosomal RNA. They signify their presence by deriving the information from mRNA and participating in protein synthesis. The cell relies on ribosomes for all its protein requirement and the amount of protein synthesized in a cell is directly proportional to the number of ribosome molecules present in the cell. S value denotes the size of the ribosome and they exist as 70s in prokaryotes and 80s in eukaryotes. 70s ribosome is the combination of 50s subunit and 30s subunit. The 50s subunit of prokaryotes has 2 rRNAs and the 30s subunit has 1 rRNA. Whereas the 60s subunit in eukaryotes possess 3 rRNAs and 40s subunit has 1 rRNA.

The occurrence of inter RNA molecule base pairing and intra molecular base pairing stabilizes the structure of the rRNA molecule. The functional proteins are found attached to the rRNAs in ribosomes. Few RNAs possess the characteristics of an enzyme and are called as ribozymes.
The process of formation of rRNA is complex involving several steps before the final product of mature rRNA. In prokaryotes, the RNA polymerase mediated transcription of rRNA genes results in the formation of pre-rRNA. The pre-rRNA exists in folded form and base pairing occurs resulting in the formation of stem-loop structure. This is followed by binding of ribosomal proteins to the folded pre-rRNA and modification of bases by methylation and action of RNAse III on specific points on rRNA causing cleavage and finally trimming the 5′and 3′of the rRNA by the M5, M16 and M23 ribonucleases resulting in the formation of mature rRNA. In eukaryotes, the steps involved in the formation of mature rRNA are similar to prokaryotes except for the additional step of ribonuclease activated trimming in prokaryotes.

Messenger RNA (mRNA): The carriers of information from DNA to the ribosome and poses as the template for synthesis of proteins. RNA polymerase II activated transcription of genes addressing proteins in nucleus results in the formation of mRNA. The format of coding regions separated by the non coding region exists in eukaryotes. The coding regions are called as Exons and the non-coding regions are called as Introns. Like the other two RNAs, mRNA formation is also initiated by the formation of pre-mRNA by transcription of both the coding and non-coding regions present as such. This is followed by a process called as splicing which removes the introns allowing the continuity of the Exons, making it an exact template for protein synthesis. Capping and polyadenylation occurs post splicing. Capping process protects the 5′ end of mRNA from the action of exonucleases and polyadenylation protects the 3′ end of the mRNA. All this described processes are skipped by the prokaryotes as the information is translated much earlier even before the completion of the transcription itself.

The transfer RNA and ribosomal RNA are considered stable whereas the life span of the messenger RNA is short.

Role of DNA in Disease Diagnosis and Medical Forensics

$
0
0
It's a universal and a scientifically proven fact that DNA carries the genetic material of an organism. DNA analysis is diagnostically proven as very useful and a sensitive tool. In this modern diagnostic DNA analyses can diagnose inherit genetic defect and also disease causing pathogen can be detected by identifying genes of that organism. Furthermore, each person’s genome is structurally unique which helps in the field of medical forensics. The DNA analysis in disease diagnosis and medical forensics involves procedures like- hybridization technique, DNA profiling, etc.

In the laboratory, to begin with, it is very essential to identify a specific DNA sequence. Nucleic acid hybridization is one such tool to be reliable on for DNA analysis. The DNA probes, are used in this technique are synthetic single-stranded DNA molecule which recognizes and binds to the specific target DNA to be analyzed. The technique basically involves the single stranded target DNA bound to membrane support and addition of DNA probes, which in presence of specific circumstances binds to the complementary target DNA. Now the sequence of the target DNA can be analyzed on the basis of the sequence of known DNA probes complementary to the target DNA. The hybridization technique involves two kinds: radioactive and non-radioactive i.e., DNA probe tagged with radioactive isotope and DNA probed untagged. Non-radioactive labeled system has an advantage over radioactive labeled system that they are quite stable (biotin labeled DNA) at room temperature even for an year. The use of probes for disease diagnosis has several advantages over conventional methods like, they are simple, rapid, highly specific, powerful when combined with PCR, and viral infections can also be detected.

Another technique is DNA chip-microarray which contains thousands of DNA probes on a glass slide on which thousands of target DNA molecules can be scanned at a time. In this method, by the use of restriction enzymes DNA molecules are cut into fragments and labeled by fluorescent markers. These reacts with probes on the DNA chip i.e. bind according to their complementary sequences. The target DNA is identified by fluorescence emission which is recorded by the computer and DNA is identified.

In the diagnosis of infectious diseases the DNA analysis is a novel approach to identify the very specific pathogen. This is incorporated by genetically engineered techniques or DNA probes or direct DNA analysis. A specific DNA diagnostic test for malaria for identification of P. falciparum is developed, where in even as little as 1ng of P. falciparum is detected; in this method the DNA probe is bound and hybridized with DNA of P. falciparum genome and not with any other species of Plasmodium. Now even radioisotope labeled DNA probes are available for diagnosis of HIV DNA. Diagnostic tool for tuberculosis is developed by genetic engineering in bacteriophage using luciferase enzyme, this involves flash of light which confirms tuberculosis. Also diseases like lyme, periodontals and chagas’ have been diagnosed using PCR amplification, DNA probes and genetically engineered DNA probes.

Genetic diseases have ailments that are manageable but there is no cure except for gene therapy. But if, the gene identification is done for that genetic disease there are chances of development of management therapy, development of precautions to reduce its risk and helpful in terminating the foetuses affected. Foetal cells are obtained by amniocentesis or biopsies of trophoblastic villi and are detected by methods like- karyotype analysis, enzyme assays, hybridization technique or RFLP analysis. Then comes identification of gene causing genetic diseases in which first step is to do pedigree analysis where in the inheritance of the disease showing high incidences in the family is examined, followed by analysis of the identified region using STRs (Short Tandem Repeats) which would result in genome mapping and identification of the most likely gene causing genetic disorder is confirmed using blotting techniques, RT-PCR or northern hybridization.

Few examples of DNA analysis in genetic disease diagnosis are: (i) Sickle cell anemia can be detected by digesting mutant and normal β-globin gene and performing hybridization with a cloned β-globin DNA probe. (ii) Huntington’s disease can be diagnosed by the analysis of RFLPs in blood related individuals. (iii) Alzheimer’s disease, researchers have found a gene on chromosome number 21 which is believed to be responsible for inheriting this disease and they developed a DNA probe that located the genetic marker for this disease. There are also diagnostic systems developed and are is underdevelopment to detect the disease by DNA analysis for diseases like- fragile X syndrome, Friedrich’s ataxia, cystic fibrosis, muscle dystrophy, diabetes, cancers, obesity, etc.

There are other human diseases which are detected by DNA analysis. These includes: deafness- where mutation of the gene on chromosome 5 causes defective protein synthesis and disassembly of actin molecules, which in turn results is deafness, baldness- alopecia universalis known as inherited form of baldness is associated with a gene located on chromosome 12. Other diseases include Glaucoma, Parkinson’s disease, etc.

In the medical forensics, DNA analysis has proven to be genetic detective in settling paternity disputes, identification of criminals, thieves, rapists, etc. This novel term and technique was developed by Alec Jaffrey’s in 1985 called as DNA Profiling also widely better known as DNA fingerprinting. This procedure does not require a large quantity of DNA but minute quantities of DNA from skin fragments, hair, semen, blood stains are enough which are amplified using PCR. DNA fingerprinting is analysis of the nitrogenous base sequence in DNA of an individual which is unique in each person. The markers used in DNA fingerprinting as well as in disease diagnosis are microsatellites or simple tandem repeats, minisatellites or variable number tandem repeats, single nucleotide polymorphisms and Restriction Fragment Length Polymorphism. Also, it is now possible to carry out DNA profiling by automated DNA detection system.

RNAi and its Role in Therapeutics

$
0
0
RNA interference (RNAi) as a therapeutic strategy.

Forward genetics has proved to be useful in the detection of the function of the genes in the early days with the help of the knowledge about the phenotype of the mutant gene. However, with the development of technology, reverse genetics has proved to be a better and effective method for the discovery of gene function due to the development of genome sequencing technology, which helped in the discovery of a number of genes without knowing their function. The general method of homologous recombination mediated gene targeting for reverse genetics proved costly, which led to the development of other approaches such as Antisense technology using antisense oligonucleotides as well as the use of ribozyme technology, which also has only limited utilities. Research related to the development of other methods for reverse genetics led to the discovery of the small interfering RNA technology, which showed great promise in revolutionalizing the approach of reverse genetics by knocking down the expression of a particular gene in the vertebrate cells. This technology of using double stranded RNA (dsRNA) to silence specific genes is known as the RNAi technology.

RNA interference involves two types of RNA molecules-micro RNA (miRNA) and small interfering RNA (siRNA). The RNAs are direct products of genes, which produce specific mRNAs by transcription. The siRNAs are duplex RNA molecules 20-25 nucleotides long, which are formed from the long dsRNA by enzymatic cleavage catalysed by Dicer, cytoplasmic RNaseIII enzyme. One of the strands of this siRNA known as the passenger strand is degraded, while the other strand known as the guide strand becomes a part of the RISC (RNA-induced silencing complex) or iRNP complex. It then base pairs with the complementary sequence of the mRNA molecule within the cell and induces its cleavage by the catalytic part of the complex, Argonaute proteins that are actually endonucleases. In this way, the siRNAs prevent the translation of the mRNAs by initiating their degradation. This process is known as RNA interference, which is a posttranscriptional event.

The Pathway of RNAi has some salient features such as the involvement of dsRNA and highly efficient and potent silencing of specific genes with minimum effort that can be introduced in various developmental stages. It has also found application in the identification of different components of various cellular pathways by systemic gene silencing, hence can be used for the development of various targeted and personal therapeutics. RNAi approach has also been useful in cancer therapy as it helps in the knocking down the expression of the anti-apoptotic genes or the cell cycle genes. Research studies have proved the presence of miRNAs in the fragile areas of genome associated with cancer, hence miRNAs may have role in tumor suppression. In some cases miRNAs may function as oncogenes as some studies have found the association of miRNA mutation with various cancers. Studies have shown that some miRNAs may bind to complementary regions in the promoter and may upregulate the expression of some genes, though it has not been clearly illustrated. Hence, miRNAs are also known as Oncomirs, due to their role in cancer.

RNAi has important role in generating immune response against different viruses and has found application in the prevention of self-propagation of the transposons in plants. The novelty of RNAi approach using endogenous mechanism shows great promise in the field of functional genomics that is spreading into the therapeutics. In future, it may offer therapeutics for different metabolic diseases including diabetes, various neurodegenerative diseases, and cardiovascular diseases, which originate from the faulty expression of tissue-specific genes. Hence, it has become a valuable and effective research tool for the biotechnological studies of both living organisms and cell cultures.

However, there are two main challenges in the development of RNAi as therapy. Firstly, the off target effects of RNA interference must be avoided for which in-depth study of the different mechanisms leading to non-specific effects of siRNA is needed and secondly, the efficient delivery of the synthetic siRNAs or iRNA into the specific cell or tissue is very essential for proper development of therapeutic utility of the RNA interference. The use of viral vectors in the delivery of the therapeutic siRNAs into the specific tissues or cells has some safety concerns, which has prompted detailed delivery-related research. RNAi has also found application in the genome wide high-throughput screening of the genes responsible for loss of function as well as genes responsible for specific biological phenotypes. Hence, due to great potential of RNAi in therapeutics, pre-clinical study using this technology is becoming essential.

Biosensors: Mechanism And Applications

$
0
0
A biosensor is a device for the detection of an analyte that combines a biological component with a physicochemical detector component.

An analytical device which functions to analyse a sample for the presence of a specific compound is known as sensor. A sensor which utilizes biological material to specifically interact with an analyte is known as biosensor. An analyte refers to the compound which has to be ‘sensed’ or the presence of which has to be determined. The interaction of analyte and biosensor is measured and converted to signals, which are again amplified and displayed. A biosensor thus involves converting a chemical flow of information into electrical signals. The biological materials used in biosensors are mostly enzymes, antibodies, nucleic acids, lectins, a cell as a whole etc.

According to the mode of interaction biosensors are of two types:
Catalytic biosensor: The interaction of biological material in the biosensor and the analyte result in modification of analyte into new chemical molecule. The biological material used is mainly enzymes.
Affinity biosensor: Here, upon interaction, the analyte binds to the biomolecule on the biosensor. These are mainly composed of antibodies, nucleic acids etc.

Essential properties of a biosensor:
(i) Specificity: a biosensor should be specific to the analyte which it interact.
(ii) Durability: it should withstand repeated usage.
(iii) Independent nature: It should not be affected by variations in the environment like temperature, pH etc.
(iv) Stability in results: the results produced by interaction should be corresponding to the concentration of analyte.
(v) Ease of use and transport: it should be small in size so that it can be easily carried and used.

Components and mechanism of a biosensor:
A biosensor mainly consists of two parts
(i) a biological part: this constitutes of enzymes antibodies etc., which mainly interacts with the analyte particles and induce a physical change in these particles.
(ii) a transducer part: which collects information from the biological part, converts, amplifies and display them. In order to form a biosensor, the biological particles are immobilized on the transducer surface which acts as a point of contact between the transducer and analyte.
When a biosensor is used to analyse a sample, the biological part specific to the analyte molecules, interacts specifically and efficiently. This produces a physicochemical change of the transducer surface. This change is picked up by the transducer and gets converted into electric signals. These then undergo amplification, interpretation and finally display of these electric units accounting to the amount of analyte present in the sample.

Types of biosensors:
(i) Calorimetric biosensor: some enzyme- analyte reactions are exothermic and releases heat into the sample. This change in temperature is detected by the transducer. The amount of heat generated is proportional to the analyte concentration present and is processed likewise.
(ii) Potentiometric biosensor: an electric potential is produced as a result of interaction which is detected by the transducer
(iii) Amperometric biosensor: analyte when comes in contact with biological material induces a redox reaction. This results in movement of electrons which is picked up by transducer.
(iv) Optical biosensors: in this, a biosensor reacts with analyte to absorb or release light which is identified by the transducer and interpreted.
(v) Acoustic wave biosensors: biological component of biosensor undergoes a biomass change ascertained by transducer.
The advantages of biosensors include accuracy in results, minute detection capability, ease of use, versatile and continuous monitoring available.

Applications:
A biosensor has a wide range of applications in different fields.
Medicinal Application: biosensors have been used in various diagnostic procedures to determine various tests.
Industrial application: various manufacturing processes can be monitored by biosensors to provide assistance with regard to increase the quality and quantity of product obtained.
Environmental application: it helps in measuring the toxicity of water bodies, microbial contamination of natural resources helping in developing steps towards a cleaner environment.
Military application: it helps to detect explosives, drugs etc., aiding in defence of the people. Another breakthrough in the field of biosensors was the production of a product called ‘smart skin’. It is a kind of biosensor which detects any chemical or biological attack nearby and warns the person using the same.
Drug development: a biosensor called ‘nano sensors’ has been developed which detects and analyse the binding of proteins to its targets which has proved very useful in drug designing. This also helps to monitor certain side effects caused by some medicines.

Altering Enzymes For Better Performance-Enzyme Engineering

$
0
0
Enzymes are biocatalysts which are mainly biological molecules which have the ability to influence a reaction. Enzyme engineering deals with enhancement of enzyme activity of existing enzyme or inducing a new enzyme activity. This is obtained by modifying amino acids sequence of the enzyme. This is made possible by recombinant DNA technology. It modifies the genes coding for amino acids of enzymes, transfer enzyme responsible genes from low active microbes to higher active ones. Multiple genes are transferred into single organism for increased expression.
The principle behind enzyme engineering is ultimately modification of amino acids of enzymes which results in a change in the property of the enzymes. The changes brought about are mostly visible in the primary structure of proteins coded by amino acids. It is not possible to alter the protein functions by modifying any sequence of amino acids. The properties of an enzyme can be altered by introduction of changes only in the specific regions of the amino acids. Therefore, it becomes necessary that the genes coding for such portions be identified and then modified as required.
The properties which are usually targeted for improvements by enzyme engineering are- kinetic properties, allosteric regulation; specificity; effect of factors like temperature, solvents, pH; etc
Various steps involved in enzyme engineering is
(i) Study of enzymes: the particular enzyme is first isolated and the desired properties are studied. Factors affecting its properties like structure are studied extensively including the primary, secondary, tertiary structure. Various techniques like NMR are employed for these studies.
(ii) Molecular modelling: Once the structure and its coding sequences are known, it is possible to estimate the effect of amino acid modification on the structure and consecutively on the function. Gathering together all the information, molecular modelling is carried out to determine the actual level of effect and whether any other further modification is needed.
(iii) Site directed mutagenesis: this process involves controlled alteration of genes at specific sites at specific bases. The genes responsible for the amino acid is first isolated and cloned using site directed mutagenesis to obtain a gene construct. A recombinant DNA construct so produced is introduced into a host organism and expressed to produce modified amino acids. The changes in amino acids are reflected in the properties of enzymes produced by recombinant DNA from the native enzymes.
.
Advantages of enzyme engineering are many like, enhanced reaction rate, less influence of physical factors, greater stability. This can be used to enhance the productivity of industrially important enzymes and thus helps in high rate of production. It is also possible that different properties of same enzyme be modified by different mechanisms, to result in double the activity of same enzyme.

Successful examples of enzyme engineering;
Subtilisin: This is an enzyme isolated from Bacillus amyloliquefaciens. This serves as a proteolytic enzymes mostly having application in the production of detergents. The enzyme has been modified so as to improve its properties like stability to temperatures, pH and oxidation conditions. The modification of these properties of this enzyme helps in its enhanced activity resulting in better quality detergent.
In this enzyme, the specificity to different peptides is coded by amino acids in the P1 cleft of the enzyme. Regulation of amino acid sequence results in the increased specificity and affinity of enzyme to only related peptides. Thus the property of specificity was enhanced. Similarly, several studies revealed that the enzyme becomes inactivated in the presence of bleaches as a result of release of oxygen molecules during the reaction. This oxidation reaction resulted in affecting the methionine at position 222(Met 222) of the amino acids resulting in formation of sulphoxide and consequent inactivation of enzymes. On replacement of the met222 by serine or alanine, the enzyme was modified to become stable against oxidation by bleaches.
Lactate dehydrogenase: It is an enzyme obtained from Bacillus stearotherophilus. This enzyme can be modified to shift its specificity from lactate to maleate. The specificity was found to be linked to presence of amino acid glutamine at position 102. When this was replaced with another amino acid arginine, the enzyme underwent a specificity change from lactate to maleate.

Enzymes in its native form have many widespread applications. But often the availability becomes scarce accounting to a higher cost of production for industrially important enzymes. Enzyme engineering is looked upon to modulate or produce new enzyme with maximum efficiency and high yield.



Get a promising and rewarding career

$
0
0
Engineering is an ever growing field, with over 250 different engineering specializations. Here we would be discussing about safety engineering courses. Among the safety engineering course programs out there, fire & safety Engineering is one of the most sought after engineering specializations. This is because a professionally trained fire engineer or fire fighter will get a promising careers as well as lucrative job openings in Gulf and European countries.
Fire safety engineering will help you make wise use of scientific education and engineering technology, to protect people and property from the risk of unexpected fire accidents. A degree in fire engineering will open doors to a promising world, with a lot of job opportunities in public as well as private sector.
Fire safety engineering, for workplace health and safety, focuses mainly on the products and processes to be used to develop fire safety procedures, and reduce the risks of fire accidents. Fire protection engineers analyze the causes and effects of fires and explosions, and will find effective methods to protect people and property. The will also design methods to control fires, and advice people about fire related hazards.
Fire engineer’s job involves a lot of risks, but it’s often a rewarding endeavor. Fire engineering training sessions have theoretical as well as practice sessions to educate aspirants and make them apply engineering and scientific principles to avert fire hazards. Fire engineers and fire fighters not only prevent, control, and alleviate fire accidents, but also assist developers in designing projects that are fireproof.

Virus - Types, Diseases and Applications

$
0
0
Viruses are smaller in size to bacteria and can also be described as nano particle stating its small size. Viruses are parasitic in nature as they always depend on a host cell or organism for replication. Viruses are known for its infectious nature, infecting right from bacteria to humans.

Virus grouping: Viruses are divided and grouped into various types using the key factors like morphology (structure), biological role, type of genetic material and mode of multiplication. The unique feature of virus is that their genetic material is covered by a protective layer termed as capsid made up of units of protein encoded by the virus itself. The association of the capsid and the genetic material (nucleocapsid) describes the structure of the virus. The viral structure has an outer envelope made up of lipoproteins and the space between the capsid and the envelope is called as Matrix which acts as a bridge between the inner nucleocapsid and the outer envelope. The matrix region is composed of proteins again.

Viruses are classified based on the type of genetic material present into DNA virus and RNA virus. DNA virus, as the name indicates have DNA as their genetic material and the DNA is either linear or circular and double stranded or single stranded. Based on the length of the genetic material present, these viruses are again divided into big and small DNA viruses. Herpes virus and pox virus are examples of double stranded DNA virus and parvo virus is single stranded DNA virus. The virus with RNA as genetic material are grouped under RNA viruses and the RNA present may be double stranded or single stranded. Also the single stranded RNA virus may have either cationic or anionic strand. Reo virus is an example of double stranded RNA virus and picorna virus is a positive single stranded RNA virus and Rhabdo virus falls under the group of negative single stranded RNA virus.

Viral Life Cycle: Virus is host specific and this nature enables them to bind themselves to the host cell. Once attached it penetrates and enters the host cell environment. The outer envelope is shed inside the host cell and mRNA is synthesized through transcription which is followed by translation into proteins. Following this is the glycosylation process and the replication begins resulting in multiple viral copies, which then assemble and exits the host cell as mature viruses.

Viral Infections: The potential of a virus to cause infection to the host cell is termed as virulence. Viruses infect bacteria, plants, animals and humans causing various reversible and irreversible diseases.
Humans: Eye infection caused by Herpes simplex virus, cytomegalo virus, encephalitis by LCM virus, Rabies virus and the occurrence of common cold is due to para influenza virus, respiratory syncytial virus. The Hepatitis virus of different groups A, B, C, D & E in causing hepatitis, a liver disease and Coxsackie B virus is identified in pancreatitis. Infection by rota virus, adeno virus and corona virus causes GI tract related diseases. HIV, Herpes simplex 2 and Human Papilloma virus are the major causative agents for the sexually transmitted diseases.

Plants: Plant viruses have different shapes like icosahedral, rod, filament or isometric. Some of the plant viruses are Tobacco Mosaic virus, cucumber mosaic virus, Lettuce mosaic virus and citrus psorosis virus. The viruses are named based on the type of disease they cause in plants.

Birds and Animals: The H1N1 episode due to the infection of birds by Influenza virus A and the infection of pigs by influenza virus (B or C) spreading swine flu are the classic examples of bird and animal viruses and their transmission to humans.

Bacteria: virus with a potential to infect bacteria is called as a bacteriophage. T4, T5, T7 phages, MS2 phage and Qβ phage are examples of the bacteriophages. The structure of a bactriophage is unique with three regions like icosahedral shape as head with shaft like middle region and tail like structures at the base.

Cancer and virus: Few viruses are detected with their ability to cause cancer in humans. The cancer causing oncogenes were first identified and studied in retrovirus. The human Papilloma virus causes cervical cancer and the chronic liver disease due to the infection by Hepatitis B virus activates the liver cells to become cancerous.

The structure, function and mode of replication enabled scientists to make use of viruses in different field of biological science. The ability of the virus to deliver the genetic material into host made them as suitable vectors in genetic engineering. The association of the virus with the immune system enabled to develop vaccines for various viral diseases. The use of virus in the field of nanotechnology is cited by the use of cowpea mosaic virus as signal amplifiers in DNA microarray technique by the researchers of Naval Research laboratory, Washington, D.C. The different perspective on virus as a tool in cancer therapy and gene therapy will be beneficial. The ability of the virus to infect bacterial cell is used to kill pathogenic bacteria (Phage therapy). Besides all this beneficial applications of virus, the threat lies in the fact that they can be used as bioweapons.

Phytoremediation Applying Biotechnological Methods

$
0
0
The technique of utilization of biological agents for degradation of pollutants is known as bioremediation. Phytoremediation is a branch of bioremediation wherein plants are employed for the purpose of removal of pollutants from a specific area.
Plants aid in phytoremediation by absorption, assimilation of compounds, vaporization of pollutants, metabolic digestion, or by microbial degradation by plant associated microbes. The plants which can accumulate and degrade the contaminants are known as ‘hyperaccumulaters’ which play a major role in phytoremediation.

Different modes of Phytoremediation
Depending on the technique applied phytoremediation can be subdivided into many kinds:
(i) Phytoextraction: it refers to a process in which plants breakdown contaminants and adsorbs the same into its tissues. After adsorption, plants can be removed from site and disposed or incinerated. Different plant types have different ability of phytoextraction and the plants with most effectiveness are chosen usually. This process is mostly used for treatment of metal pollutants in soil.
(ii) Rhizofiltrtion: in this process the pollutants gets adsorbed and deposited, not on the shoot tissues but in this case, in the root or rather in the rhizosphere of plants. This technique is specifically employed for waste removal from contaminated water sources.
(iii) Phytostabilisation: this concept involves immobilization of the pollutants following absorption and adsorption of it by plant roots and finally precipitation of the pollutant in the root so that it does not migrate from soil into air or other sources.
(iv) Phytotransformation: it deals with transformation or degradation of pollutants as a result of various metabolic processes by plants. Thus it is also known as phytodegradation.
(v) Phytovolatilization : the contaminants are absorbed by plants, undergo many changes and finally gets volatized from leaf surface during transpiration process of plants.
(vi) Phytostimulation: the microbial population near the root system of plants gets induced by the presence of rhizosphere which initiates them to break down the pollutants. This process is also known as rhizosphere degradation.

Role of biotechnology in phytoremediation:
Off late, biotechnology has been found to increase its wide spectrum of applications into phytoremediation as well. Plants adopted for phytoremediation are usually found to exhibit the specific property due to the presence the special genes coding for it. These plants are usually seen in area where metal ores exist. The genes responsible for this resistance by such plants are isolated and expressed in wide variety of transgenic plants so that they can be made resistant as well. This increases the number of plant species that can be used for such purpose. It is also possible with the help of biotechnology to increase the gene expression for maximum resistance.
Certain plants are seen to show increased resistance under the presence of certain microbes. Biotechnology makes it possible to isolate such microbes and enrich the soil so as to enhance the phytoremediation by respective plants.
Examples of application of biotechnological aspects in phytoremediation

Selenium: The micronutrient selenium is known to induce toxicity in the soil where the concentration of the same is found to be high. It is found that methylation of amino acids at specific site can result in volatilization of selenium compound. Thus a transgenic plant is constructed which has the ability to volatize the same by following the guidelines of genetic engineering and utilizing the information obtained by studying hyperaccumulators of selenium.
Mercury: Mercury can be degraded by certain bacterium due to the presence of merA and merB genes. Thus integration of these genes into certain plant genomes has seen effective mercury degradation by such transgenic plants. The genes are targeted to be expressed in chloroplasts so that after degradation into relatively less toxic form, it is volatized. Thus transgenic tobacco produced by this phenomenon was shown to exhibit mercuric resistance.
Arsenic: Certain bacterial genes present in E. coli, such as ArsC is responsible for reduction of arsenic and formation of a complex in the presence of glutathione(GSH). An increased amount of GSH can be produced by expression of glutamyl cysteine synthetase enzyme. These genes are isolated and transferred to form a transgenic plant which can effectively absorb arsenic and accumulate the same in its vacuoles resulting in phytoremediation.

Thus it can be concluded that biotechnological tools can be utilized to improvise many existing phytoremediation systems yielding more effective and faster results.



Stem Cells Help in Bone Repair

$
0
0
Many a time people lose their bones due to different types of trauma, accident, etc; hence need bones for proper functioning and in certain cases, people need bones to replace the lost ones due to bone cancer or war injuries, etc. In such cases, bone transplant was the only type of treatment available in olden days. The potential of the stem cells to replace heart tissue and even create a trachea to replace a damaged trachea, has initiated the study and research involving stem cells in other areas too. Recent studies have showed the potential of using stem cells for the repair of bones and also their use in growing certain bones within the body. Thus, extensive ongoing research studies in the field of stem cells extend the boundaries for the use and application of stem cells in different types of therapeutics.

The substitution of bones was done by the surgeons using different types of metals, plastic, etc and the procedure had the possibility of rejection of the transplant by the body. All these initiated the development of a better approach for bone repair and substitution, in which stem cells showed great promise. Recent most study has showed one of the greatest challenges met by the stem cells in growing bones. Stem cells were used to grow back the facial bones in a boy with no cheekbones. Due to the use of stem cells in growing back bones, the possibility of rejection due to a transplant was automatically removed, which helped to a great extent.

The transplant of a bone from another part of a person’s body to the site where bones need to be replaced was not very efficient in form and function. Moreover, it still faced the possibility of rejection. Hence, the use of stem cells to regenerate bones found application. Due to the formation of functional bone cells from the stem cells and thus the formation of a bone with proper function in the target site proved the importance and use of stem cells in successful bone repair and regeneration.

The stem cells used for the replacement of bones and also for growing bones were mainly extracted from the fat cells or the adipose tissue of the affected individual. Hence, this removed the necessity of donors for the transplants. The use of stem cells isolated from the fat of the affected individual also removes the possibility of any sort of immunological reaction against the stem cells as the body recognises them as its own. In most of the treatments, the immunological reaction causes hindrance, which is avoided in this case of stem cell treatment. Fat or adipose tissues are mainly selected for the purpose of stem cell isolation, as it is completely accessible besides being far more convenient, cheaper, as well as less painful for the patient. The procedure of stem cell isolation from other areas within the patient body is very much painful and time consuming. Even the recovery of the patient after the isolation procedure takes long time thereby delaying the application of the isolated stem cells. Previously, the introduction of the isolated stem cells within the body was done directly to the target site of injury, which indicated the movement of the stem cells throughout the body. This movement lead to the failure of the procedure. Hence, the isolated stem cells were then introduced within the body using a gel like substance that helped in localising the stem cells in the bone injury site thus helping in the repair of the bones by healing them.

The use of stem cells in the regeneration of bones was seen in a study involving a teenaged boy, who suffered from a rare type of inborn genetic defect, in which he had no cheekbones in his face. Replacement of cheekbones became necessary not just to improve appearance, which was a minor requirement but mainly to restore the important functions of the cheekbones such as protection of the eyes. The procedure proved successful with the regeneration of the facial bones with the stem cells extracted from the adipose tissue. Although, the procedure proved successful, the scientists have some doubt regarding the practical applicability of this procedure in all types of patients. The young age of the boy was one of the important factors that lead to the success of the procedure due to better ability of regeneration and healing at young age. The application of the procedure in an elderly individual may not meet with same success as in this case. Moreover, the functionality of the bones regenerated even after five years of the procedure need to be analysed to assess the effectiveness of the procedure entirely. Hence, in-depth research regarding the procedure is essential before it can be used for the practical application in bone repair and regeneration.

Potential role of stem cells in the therapeutics for major diseases

$
0
0
Stem cells have shown great promise in the treatment of a number of major diseases. Their unique properties of differentiation have made their studies a widely researched area. Although, there are some ethical issues surrounding the subject, the development in this area can offer solutions and therapeutics for many fatal diseases with minimal complications. However, in-depth research and scientific testing on human trials is essential before it can have wide application for treatment throughout the world.

Heart diseases are one of the major diseases affecting majority of the population all over the world. The inability of the heart cells to regenerate and repair themselves after the occurrence of a heart attack prevents the application of further treatments on such patients. In such cases, stem cells have helped in regenerating damaged heart muscle cells by the introduction of adult stem cells from non-heart tissues into the damaged heart. Hence, they play an important role in the treatment of heart diseases.

Neuronal diseases and spinal cord injuries have always been a cause of fear for people as the treatment of these diseases are quite complicated and their complete cure is quite difficult to attain. In this area also, stem cells have made a major mark with proof of successful studies in rodent models. The condition of paralysis or impairment of motor function due to spinal cord injury was found to be reversible to perfectly normal condition with the introduction of embryonic stem cells. In a motor neuron degenerative disease called Lou Gehrig’s disease also, it was found that the introduction of embryonic stem cells helped in the restoration of the function of motor nerve cells. However, all these studies were found to be successful in the rodent models; hence, they remain to be translated into the human studies. Stem cells have proved successful in the treatment of Parkinson’s disease, in which they were able to restore the secretion of neurotransmitter, dopamine, with the transplantation of the stem cells. However, there were possibilities of hypersensitivity to increased dopamine levels. Hence, detailed study is necessary before it can be translated into potential treatment.

Stem cells have provided a path for the treatment of the degenerative retinal diseases. The successful differentiation of the stem cells into photoreceptor cells and the introduction of these photoreceptor cells into the retina of the patients helped in restoring the vision of the patients, thereby preventing complete blindness. The differentiation of the stem cells into specialised pancreatic cells with the ability to secrete insulin has provided a gateway to the treatment of diabetes associated with impaired insulin secretion due to the destruction of the pancreatic β-cells by the immune system.

The stem cells have played a major role in the treatment of cancer like leukaemia and this is one of the successful applications of stem cell based therapies. The disease of Leukaemia affects the white blood cells, which become cancerous and lose their normal functioning. The ability of the normal white blood cells to fight against different infections and protect the body is lost. This results in the vulnerability of the body to develop infections as the immune system is compromised and the functionality of the different vital organs within the body is lost. The bone marrow transplant along with chemotherapy helps in replacing the damaged blood cells with fresh blood cells. The patient’s damaged cells are removed by chemotherapy and the new stem cells introduced by transplantation give rise to new blood cells, thereby restoring the functions of the blood cells. The introduction of new refinements in the technique has removed the necessity of a match between the donor and the patient’s bone marrow. The multiplication of the stem cells in the donor blood to high concentrations has removed the need for matching the donor and patient, thereby improving the patient outcome, and helping in the eradication of cancer in future.

New research studies have shown the reattachment of the lost teeth and the growth of new teeth in place of lost ones with the help of stem cells within the patient’s body, thus opening a new area of research in the field of dentistry. The ability of the stem cells to repair bones and also regenerate lost bones within the body has demonstrated the remarkable progress in the stem cell research. Thus, stem cells research has become the future for different therapeutics and can be the ultimate solution for decreasing the suffering and increasing the mortality of the mankind.

Contribution of Genetic Engineering in Improving Plant Properties

$
0
0
The techniques of gene transfer have reflected many successful examples in variety of fields. Some of the examples in the field of agricultural biotechnology are:

Resistance to herbicides: It is important that plants do not get affected on the application of herbicides. In order to install this property of resistance, different methods has been approached through means of gene transfer:
Production of target molecules: The target molecules which are resistant to action of herbidicdes are identified. The gene responsible for such target molecules are incorporated into the plant genome so that the plants produce such target molecules expressing resistance to herbicides. Eg: the gene aroA isolated from Salmonella typhimurium or E.coli is known to produce an enzyme EPSPS which is resistant to the glyphospate herbicide. Transgenic tomato and tobacco plants produced by transfer of this gene were seen to exhibit herbicide resistance.
Detoxification of herbicides: Certain plants produce enzymes which has the ability to detoxify the herbicide action. The introduction of the respective genes can induce herbicide resistance in plants. Main example for this is detoxification of atrazine herbicide by maize plants producing enzyme glutathione-S-transferase.

Resistance to insects:
In the case of developing insect resistant plants, the process involves transfer of insect resistant genes. The major breakthrough in developing resistance to insects was obtained from Bacillus thuringiensis. A gene called as ‘cry genes’ produces a protein called as cry protein which are largely responsible for insect resistance. In the bacterium, these proteins produced exhibit resistance to insects. The cry protein ingested by insects undergoes modification to release toxins in the gut region resulting in the lysis of insects. These genes have been successfully transferred to the genome of plants like tobacco, potato and tomato. Such transgenic plants are found to exhibit resistance to insects like Manduca sexta and Heliothis virescens. Over a period of time, it was found that insects were developing resistance against such proteins. Combating to this, development of transgenic plants expressing alternate form of cry protein but maintaining its toxicity was introduced. The modified cry genes showed greater levels of expression and toxicity.

Virus resistance:
Several strategies have been followed for developing virus resistance in plants. It includes expression of coat proteins, developing cDNA from satellite RNA, degradation of viral genome, antisense RNA approach, and production of viral specific RNAase.
Of these, the technique involving expression of coat protein has met with high level of efficiency. The transgenic plants produced were integrated with genes responsible for producing viral coat proteins. This helped to reduce viral replication thus developing viral resistance.

Bacterial resistance:
In developing resistance against bacteria, different approaches targeting the growth and development of bacteria or bringing about degradation of toxins released have been applied. Of this the most successful phenomenon was that of artificial cell death. In response to certain stimuli the cell of certain organisms produces proteins which bring about the death of cells. Such mechanism is known as programmed cell death. In transgenic plants this capability of cell death was modified so that the infected cells gets targeted and trigger a response of artificial cell death leading to the death of infectious agent. This phenomenon is found to be active against fungi infection also.

Drought resistance:
Several genes has been identified which show increased response to abiotic stress like abscisic acid, osmotic stress etc. Some of the genes involved are:
Rab which respond to abscisic acid; SalT responsive against salt stress and proBA and proC involved in proline biosynthesis.
The genes responsible for proline biosynthesis when isolated and expressed in transgenic plants resulted in high expression and consequent development of resistance to osmotic pressure was indicated. This resistance was possible due to the deposition of proline in the cells which helps in regulating water activity of the cell. Certain other genes like mtl1D from E.coli have been seen to express mannitol accumulation in cells which aid in plant growth under non favourable conditions.

Improving seeds quality:
Certain seeds produced by native plants have been found to be deficient in some important nutrient lowering the seed quality. With the help of genetic engineering, the seed quality can be increased so as to produce economically important seeds. The basis of this is, introduction of genes into the genome corresponding to the production of missing nutrient or modification of endogenous genes of plants to produce seeds of high quality. Eg:- In peas, the seed produced has lesser sulphur containing amino acids. Such amino acids are rich in sunflower seeds. The integration of gene encoding for such amino acids in peas seeds and expression in transgenic tobacco, led to the production of seeds with the respective amino acids in adequate amounts.
Viewing all 2695 articles
Browse latest View live




Latest Images